FDA Approved: PIFELTRO — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved a supplemental application for PIFELTRO (doravirine) by Merck Sharp & Dohme LLC, expanding its label for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PIFELTRO (doravirine)

Snippet

SUPPL AP for PIFELTRO (DORAVIRINE)